Westbury, Leo D.
Fuggle, Nicholas R. http://orcid.org/0000-0001-5463-2255
Pereira, Diogo
Oka, Hiroyuki
Yoshimura, Noriko http://orcid.org/0000-0002-6555-5782
Oe, Noriyuki
Mahmoodi, Sasan
Niranjan, Mahesan http://orcid.org/0000-0001-7021-140X
Dennison, Elaine M. http://orcid.org/0000-0002-3048-4961
Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Funding for this research was provided by:
Medical Research Council (MRC_MC_UP_A620_1014, MC_PC_21003, MC_PC_21001)
Article History
Received: 6 January 2023
Accepted: 26 April 2023
First Online: 19 May 2023
Declarations
:
: CC reports personal fees (outside the submitted work) from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestle, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB. EMD reports personal fees and honoraria (outside the submitted work) from UCB, Pfizer, Lilly and Viatris. NRF has received travel bursaries from Pfizer and Eli Lilly. The remaining authors declare that they have no conflicts of interest.
: The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2000. The baseline Hertfordshire Cohort Study had ethical approval from the Hertfordshire and Bedfordshire Local Research Ethics Committee and the follow-up had ethical approval from the East and North Hertfordshire Ethical Committees.
: All participants provided written informed consent to participate in the study and for their health records to be accessed in the future.